Royal Capital Wealth Management, LLC Biogen Inc. Transaction History

Royal Capital Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $6,455 - $7,770	-29 Reduced 2.24%	1,266 $327,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $4,104 - $4,677	-16 Reduced 1.22%	1,295 $360,000
Q2 2022 Aug 16, 2022	SELL	$187.54 - $223.02 $33,757 - $40,143	-180 Reduced 12.07%	1,311 $267,000
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $775 - $976	-4 Reduced 0.27%	1,491 $314,000
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $334,760 - $430,216	1,495 New	1,495 $359,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.